Merck (MRK) Income from Non-Controlling Interests (2009 - 2026)
Merck (MRK) reported Income from Non-Controlling Interests of -$3.0 million for Q1 2026, down 150.0% year-over-year from $6.0 million in Q1 2025, and down 200.0% on a QoQ basis from -$1.0 million in Q4 2025.
Merck (MRK) has 18 years of Income from Non-Controlling Interests data on file, last reported at -$3.0 million in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 150.0% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 105.88% YoY) and the FY2025 annual result came in at $9.0 million, down 43.75% from the prior year.
- Income from Non-Controlling Interests eased to -$3.0 million in Q1 2026 per MRK's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $6.0 million in Q2 2024 and bottomed at -$3.0 million in Q1 2022.
- The 5-year median for Income from Non-Controlling Interests is $3.5 million (2023), against an average of $2.6 million.
- The widest annual swing landed in 2022, when Income from Non-Controlling Interests soared 400.0%; it then slumped 200.0% in 2025.
- Tracing MRK's Income from Non-Controlling Interests over 5 years: stood at $1.0 million in 2022, then soared by 400.0% to $5.0 million in 2023, then plunged by 80.0% to $1.0 million in 2024, then tumbled by 200.0% to -$1.0 million in 2025, then tumbled by 200.0% to -$3.0 million in 2026.
- Per Business Quant, the three latest MRK Income from Non-Controlling Interests figures stand at -$3.0 million (Q1 2026), -$1.0 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 2.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -3.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 8.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | -1.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | -3.00 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 4.00 Mn |
| Dec 31, 2020 | 3.00 Mn |
| Sep 30, 2020 | 2.00 Mn |
| Jun 30, 2020 | 4.00 Mn |
| Dec 31, 2019 | -11.00 Mn |
| Sep 30, 2019 | 6.00 Mn |
| Jun 30, 2019 | -26.00 Mn |
| Mar 31, 2019 | -53.00 Mn |
| Dec 31, 2018 | -49.00 Mn |
| Sep 30, 2018 | 8.00 Mn |
| Jun 30, 2018 | 9.00 Mn |
| Mar 31, 2018 | 5.00 Mn |
| Dec 31, 2017 | 8.00 Mn |
| Sep 30, 2017 | 5.00 Mn |
| Jun 30, 2017 | 5.00 Mn |
| Mar 31, 2017 | 5.00 Mn |
| Dec 31, 2016 | 8.00 Mn |
| Sep 30, 2016 | 4.00 Mn |
| Jun 30, 2016 | 4.00 Mn |
| Mar 31, 2016 | 5.00 Mn |
| Dec 31, 2015 | 5.00 Mn |
| Sep 30, 2015 | 5.00 Mn |
| Jun 30, 2015 | 1.00 Mn |
| Mar 31, 2015 | 5.00 Mn |
| Dec 31, 2014 | 11.00 Mn |
| Sep 30, 2014 | -53.00 Mn |
| Jun 30, 2014 | 29.00 Mn |
| Mar 31, 2014 | 26.00 Mn |
| Dec 31, 2013 | 34.00 Mn |
| Sep 30, 2013 | 26.00 Mn |
| Jun 30, 2013 | 29.00 Mn |
| Mar 31, 2013 | 23.00 Mn |
| Dec 31, 2012 | 42.00 Mn |
| Sep 30, 2012 | 34.00 Mn |
| Jun 30, 2012 | 27.00 Mn |
| Mar 31, 2012 | 29.00 Mn |
| Dec 31, 2011 | 31.00 Mn |
| Sep 30, 2011 | 32.00 Mn |
| Jun 30, 2011 | 30.00 Mn |
| Mar 31, 2011 | 28.00 Mn |
| Dec 31, 2010 | 32.00 Mn |
| Sep 30, 2010 | 30.00 Mn |
| Jun 30, 2010 | 28.00 Mn |
| Mar 31, 2010 | 31.00 Mn |
| Dec 31, 2009 | 29.20 Mn |
| Sep 30, 2009 | 31.00 Mn |
| Jun 30, 2009 | 32.00 Mn |
| Mar 31, 2009 | 30.80 Mn |